ERBB2 and breast cancer: Finally, molecular subtypes of the 135 BC were: 57 Luminal A (42.22%), 21 Luminal B-like Her-2 neg (15.55%), 21 Luminal B-like Her-2 pos (15.55%), 21 Her-2 overexpressing (15.55%) and 15 Triple negative (11.11%).